Volpara Health Technologies Limited
VPAHF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.50 | 2.30 | 0.65 | -0.16 |
| FCF Yield | -3.23% | -5.74% | -4.26% | -10.29% |
| EV / EBITDA | -25.35 | -14.95 | -18.05 | -6.67 |
| Quality | ||||
| ROIC | -17.77% | -26.86% | -21.88% | -35.17% |
| Gross Margin | 92.45% | 91.23% | 91.43% | 85.98% |
| Cash Conversion Ratio | 0.39 | 0.69 | 0.80 | 0.78 |
| Growth | ||||
| Revenue 3-Year CAGR | 21.82% | 25.36% | 48.99% | 67.09% |
| Free Cash Flow Growth | 53.56% | 8.12% | 14.21% | -52.33% |
| Safety | ||||
| Net Debt / EBITDA | 1.46 | 1.05 | 1.48 | 1.38 |
| Interest Coverage | -29.03 | -111.18 | -128.79 | -299.98 |
| Efficiency | ||||
| Inventory Turnover | 1.95 | 1.26 | 31.92 | 32.82 |
| Cash Conversion Cycle | 152.03 | 217.28 | -34.03 | 47.92 |